Waltermire Robert E. - SEC Form 4 Insider Trading Screener

General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
6 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2024-06-14
MDGLWaltermire Robert E.SVP, Chief Pharma Dev.S - Sale+OE$280.00-1,9005,500-26%-$532,000
D
2024-06-12
MDGLWaltermire Robert E.SVP, Chief Pharma Dev.S - Sale+OE$285.00-2,0005,500-27%-$570,000
2024-05-21
MDGLWaltermire Robert E.SVP, Chief Pharma Dev.S - Sale$231.34-1,0365,500-16%-$239,668
DM
2023-12-14
MDGLWaltermire Robert E.SVP, Chief Pharma Dev.S - Sale+OE$235.50-4,0005,667-41%-$942,000
DM
2023-12-12
MDGLWaltermire Robert E.SVP, Chief Pharma Dev.S - Sale+OE$222.82-3,8005,667-40%-$846,700
DM
2023-02-28
MDGLWaltermire Robert E.SVP, Chief Pharma Dev.S - Sale+OE$273.24-10,0005,667-64%-$2,732,438

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top